SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-21-014570
Filing Date
2021-11-04
Accepted
2021-11-04 16:01:49
Documents
14
Period of Report
2021-11-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K coll-20211104x8k.htm   iXBRL 8-K 39991
2 EX-99.1 coll-20211104xex99d1.htm EX-99.1 243741
3 GRAPHIC coll-20211104xex99d1001.jpg GRAPHIC 10048
  Complete submission text file 0001558370-21-014570.txt   437122

Data Files

Seq Description Document Type Size
4 EX-101.SCH coll-20211104.xsd EX-101.SCH 3230
5 EX-101.LAB coll-20211104_lab.xml EX-101.LAB 16166
6 EX-101.PRE coll-20211104_pre.xml EX-101.PRE 10954
7 EXTRACTED XBRL INSTANCE DOCUMENT coll-20211104x8k_htm.xml XML 4883
Mailing Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072
Business Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072 781-713-3699
COLLEGIUM PHARMACEUTICAL, INC (Filer) CIK: 0001267565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37372 | Film No.: 211379804
SIC: 2834 Pharmaceutical Preparations